Counterpart to Registration Rights Agreement March 20, 2015
EX-10.248 11 ex10248endorracounterpartr.htm RRA 2023 NOTES Ex. 10.248 Endo RRA Counterpart re 2023 Notes March 20 2015
Exhibit 10.248
Counterpart to Registration Rights Agreement
March 20, 2015
Each of the undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated June 30, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, Citigroup Global Markets Inc. and RBC Capital Markets, relating to the 5.375% Senior Notes due 2023, to be bound by the terms and provisions of such Registration Rights Agreement.
Exhibit 10.248
IN WITNESS WHEREOF, each of the undersigned has executed this counterpart as of the date first written above.
APHRODITE WOMEN’S HEALTH, LLC | |
as a Guaranteeing Subsidiary | |
By: | AMERICAN MEDICAL SYSTEMS |
HOLDINGS, INC., its manager | |
By: | /s/ Deanna Voss |
Name: | Deanna Voss |
Title: | Assistant Secretary |
ENDO VENTURES CYPRUS LIMITED | |
as a Guaranteeing Subsidiary | |
By: | /s/ Orla Dunlea |
Name: | Orla Dunlea |
Title: | Director |
[Signature to Registration Rights Agreement Counterpart - 5.375% Senior Notes due 2023]
